Outset Medical, Inc.
OM
$3.53
$0.051.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.09% | 4.65% | 2.47% | -7.84% | -12.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.09% | 4.65% | 2.47% | -7.84% | -12.80% |
| Cost of Revenue | -2.74% | -5.10% | -8.86% | -21.36% | -26.15% |
| Gross Profit | 20.13% | 26.01% | 30.77% | 32.80% | 33.62% |
| SG&A Expenses | -17.28% | -22.44% | -26.35% | -23.87% | -20.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.40% | -20.37% | -24.69% | -26.89% | -25.17% |
| Operating Income | 38.80% | 43.64% | 46.51% | 42.00% | 34.82% |
| Income Before Tax | 36.51% | 37.87% | 38.55% | 32.63% | 26.00% |
| Income Tax Expenses | 46.23% | 1.98% | -22.31% | -9.94% | -6.12% |
| Earnings from Continuing Operations | 36.20% | 37.70% | 38.50% | 32.56% | 25.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.20% | 37.70% | 38.50% | 32.56% | 25.94% |
| EBIT | 38.80% | 43.64% | 46.51% | 42.00% | 34.82% |
| EBITDA | 39.61% | 45.01% | 48.03% | 43.42% | 36.02% |
| EPS Basic | 81.63% | 68.50% | 57.53% | 42.89% | 29.32% |
| Normalized Basic EPS | 84.10% | 70.95% | 59.31% | 44.09% | 30.81% |
| EPS Diluted | 81.63% | 68.50% | 57.53% | 42.89% | 29.32% |
| Normalized Diluted EPS | 84.10% | 70.95% | 59.31% | 44.09% | 30.81% |
| Average Basic Shares Outstanding | 335.93% | 236.71% | 134.91% | 31.21% | 4.99% |
| Average Diluted Shares Outstanding | 335.93% | 236.71% | 134.91% | 31.21% | 4.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |